EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characteristics of gut microbiota in high-methylated colorectal cancer

Tatsushi Saito, Hideaki Karasawa, Kota Ouchi, Tomoyuki Ono, Taiki Kajiwara, Atsushi Kohyama, Wakako Ikeda-Ohtsubo, Shinji Fukuda, Fumiyoshi Fujishima, Yohei Ozawa, Hideyuki Suzuki, Kazuhiro Watanabe und 5 weitere

International Journal of Clinical Oncology · 2025

DOI: 10.1007/s10147-025-02812-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Clinical Oncology, 2025. Verfasst von Tatsushi Saito und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-Ku, Sendai, 980-8574, Japan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, DNA Methylation, Gastrointestinal Microbiome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development (AMED), Japan Society for the Promotion of Science (JSPS) KAKENHI, Clinical Research Promotion Program for Young Investigators of Tohoku University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Epigenetic alterations, including DNA methylation, significantly contribute to colorectal cancer (CRC); the gut microbiota is also involved. However, studies on the possible role of microbiota in DNA methylation are limited. This study investigates the association between gut microbiota composition and high-methylated CRC (HMCC).

Methods

Fecal and tumor tissue samples were collected from 86 patients with sporadic CRC. HMCC was defined based on the methylation status of 16 CpG sites of tumor-derived genomic DNA. 16S rRNA gene sequencing was performed to reveal the composition of the gut microbiota. The load of Fusobacterium nucleatum (F. nucleatum) in tumor tissues was assessed using quantitative polymerase chain reaction (qPCR).

Results

HMCC was identified in 21 patients, whereas 65 were classified as having low-methylated CRC (LMCC). HMCC was significantly associated with proximal location, large diameter, undifferentiated histology, and high frequency of BRAF mutation. In gut microbial analyses, the relative abundances of 84 bacteria, including F. nucleatum, were significantly different between HMCC and LMCC. The load of F. nucleatum in CRC specimens was significantly correlated with its relative abundance in fecal samples and tended to be enriched in HMCC tissues.

Conclusions

This study characterizes the gut microbiota profile in HMCC and suggests that bacteria, such as F. nucleatum, may contribute to HMCC pathogenesis through DNA methylation. Further studies are needed to determine whether the microbiome acts as a promoter or bystander in HMCC development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsDNA MethylationGastrointestinal MicrobiomeHumansMaleFemaleMiddle AgedAgedFusobacterium nucleatumRNA, Ribosomal, 16SFecesAdultAged, 80 and overProto-Oncogene Proteins B-rafCpG Islands

Stichwörter der Autor:innen

Colorectal cancerCpG island methylator phenotypeFusobacterium nucleatumHigh-methylated colorectal cancer

Substanzen

RNA, Ribosomal, 16SProto-Oncogene Proteins B-rafBRAF protein, human

Autor:innen und Institutionen

  • Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-Ku, Sendai, 980-8574, Japan.
  • Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-Ku, Sendai, 980-8574, Japan. hideaki.karasawa.e1@tohoku.ac.jp.
  • Department of Oncology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-Ku, Sendai, 980-8574, Japan.
  • Food and Feed Immunology Group, Laboratory of Animal Food Function, Graduate School of Agricultural Science, Tohoku University, Sendai, 980-8572, Japan.
  • Institute for Advanced Biosciences, Keio University, 246-2 Kakuganji, Mizukami, Tsuruoka, 997-0052, Japan.
  • Innovative Microbiome Therapy Research Center, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo, 113-8421, Japan.

Förderung

  • Japan Agency for Medical Research and Development (AMED)
  • Japan Society for the Promotion of Science (JSPS) KAKENHI
  • Clinical Research Promotion Program for Young Investigators of Tohoku University Hospital

Zitieren

APA

Saito, T., Karasawa, H., Ouchi, K., Ono, T., Kajiwara, T., Kohyama, A., Ikeda-Ohtsubo, W., Fukuda, S., Fujishima, F., Ozawa, Y., Suzuki, H., Watanabe, K., Ishioka, C., Kamei, T., Ohnuma, S., Abe, T., & Unno, M. (2025). Characteristics of gut microbiota in high-methylated colorectal cancer. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-025-02812-3

Vancouver

Saito T, Karasawa H, Ouchi K, Ono T, Kajiwara T, Kohyama A, et al. Characteristics of gut microbiota in high-methylated colorectal cancer. International Journal of Clinical Oncology. 2025. doi:10.1007/s10147-025-02812-3

BibTeX
@article{Saito2025,
  author = {Saito, Tatsushi and Karasawa, Hideaki and Ouchi, Kota and Ono, Tomoyuki and Kajiwara, Taiki and Kohyama, Atsushi and Ikeda-Ohtsubo, Wakako and Fukuda, Shinji and Fujishima, Fumiyoshi and Ozawa, Yohei and Suzuki, Hideyuki and Watanabe, Kazuhiro and Ishioka, Chikashi and Kamei, Takashi and Ohnuma, Shinobu and Abe, Takaaki and Unno, Michiaki},
  title = {Characteristics of gut microbiota in high-methylated colorectal cancer},
  journal = {International Journal of Clinical Oncology},
  year = {2025},
  doi = {10.1007/s10147-025-02812-3}
}
Kostenlos starten →